Remedent Company Top Insiders

Remedent Management Team Effectiveness

Remedent's management efficiency ratios could be used to measure how well Remedent manages its routine affairs as well as how well it operates its assets and liabilities. Remedent owns a total of 20 Million outstanding shares. Remedent has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it. Some institutional investors establish a significant position in pink sheets such as Remedent in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Remedent, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Remedent Workforce Comparison

The company has Profit Margin (PM) of 0.33 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.17 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.17.

Remedent Benchmark Summation

Remedent Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Remedent often depends on how effective the management is. Remedent management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Remedent management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Remedent management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

When running Remedent's price analysis, check to measure Remedent's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Remedent is operating at the current time. Most of Remedent's value examination focuses on studying past and present price action to predict the probability of Remedent's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Remedent's price. Additionally, you may evaluate how the addition of Remedent to your portfolios can decrease your overall portfolio volatility.